Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Wuda granule** is an oral, hospital-prepared traditional Chinese herbal medicine previously called **Xiangbin prescription/Xiangbin Formula**. It is a five-herb mixture containing areca seed, ginseng root, Lindera aggregata root, peach kernel, and Amomum fruit. It is being investigated to accelerate recovery of gastrointestinal motility after abdominal surgery, including postoperative ileus and postoperative gastrointestinal dysfunction. Clinical and preclinical studies associate the preparation with increased gastrointestinal migrating motor complex activity, increased circulating motilin and ghrelin, cholinergic-muscarinic signaling involving intramuscular interstitial cells of Cajal, and anti-inflammatory effects; these are system-level findings rather than evidence of a single defined molecular target. ([onlinelibrary.wiley.com](https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/imm3.70016))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on wuda granule (Guangdong Provincial Hospital of Traditional Chinese Medicine).